Clinical trial
Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis Using Rituximab: A Pilot Study Evaluating Synovial Outcomes
NCT00963703 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis Using Rituximab: A Pilot Study Evaluating Synovial Outcomes
- Lead sponsor
- University of Manitoba
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2007
- Completion date
- March 31, 2012
- Enrollment
- 15 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis